BDSX
BIODESIX INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$23.40
−1.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 27.00x
- Price / sales
- 2.40x
- Price / cash flow
- -12.45x
Enterprise value
- Enterprise value
- $288.7M
- EV / sales
- 2.80x
- EV / EBITDA
- -20.19x
- EV / EBIT
- -14.02x
- Market cap
- $246.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026